InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Aguilar Laura K., Directeur Médical. Officer active across 1 company, notably Candel Therapeutics, Inc.. Aggregated, 2 filings have been published. History available since 6 May 2022. The latest transaction was filed on 6 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Aguilar Laura K. is the Chief Medical Officer of Candel Therapeutics, Inc. She is responsible for leading the company's medical and clinical initiatives, bringing her expertise in biotechnology. Her role is crucial for the development of new treatments and therapies.